PetCure Oncology says it has treated 10,000 radiation patients

PetCure Oncology says it has now treated 10,000 veterinary radiation patients since launching in 2015, a milestone the company is framing as evidence that advanced radiation therapy has moved beyond a niche academic offering and into a broader referral network. In its January 7 announcement, the Thrive Pet Healthcare affiliate said it now operates eight treatment centers nationwide and supports referrals with a clinical team that includes 12 board-certified oncologists and eight supervising veterinarians. The company’s model centers on stereotactic radiosurgery and stereotactic radiation therapy, which can often be completed in one to three sessions rather than the longer conventional protocols many clinicians historically associated with radiation oncology. (petcureoncology.com)

Why it matters: For veterinary professionals, the milestone is less about a round number than what it suggests about referral access. PetCure and affiliated experts have argued that radiation oncology remains constrained by workforce and geography, with only about 100 veterinary radiation oncologists worldwide, making telehealth-supported planning and distributed specialty models increasingly important. For general practitioners, that could mean more realistic referral pathways for cases where radiation was once dismissed because of distance, treatment burden, or limited local expertise. (petcureoncology.com)

What to watch: Watch whether PetCure’s expansion continues in 2026, including its planned Seattle launch with Empyrean Medical Systems’ Sirius platform and any further evidence that shorter-course radiation models broaden access without compromising case selection or care coordination. (empyreanmed.com)